NVCN

Neovasc Inc. - Common Shares

1.9199
USD
3.22%
1.9199
USD
3.22%
0.0214 4.5800
52 weeks
52 weeks

Mkt Cap 37.36M

Shares Out 19.46M

new Chat
Send me real-time posts from this site at my email

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action against Neovasc, Inc. (NVCN) and Lead Plaintiff Deadline: August 5, 2016

NEW YORK, NY / ACCESSWIRE / June 20, 2016 / Bronstein, Gewirtz & Grossman, LLC, notifies investors of class action against of Neovasc, Inc. ("Neovasc" or "the Company") (NVCN). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Neovasc securities during the period between January 26, 2015, and May 19, 2016, inclusive (the "Class Period").

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").

Neovasc is a specialty medical company that develops cardiovascular products. Neovasc's primary product is the Tiara, a transcatheter mitral valve device used to treat mitral valve disease. This device can be implanted through minimally invasive surgery to patients with mitral regurgitation resulting from mitral heart valve disease.

The Complaint...


More